Get Live Data

Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE
REMOVE ADS
REMOVE ADS

Latest Share Chat

  2. Share Prices
  3. Glaxosmithkline Share Price
  4. Glaxosmithkline Share Regulatory News
  5. Block Listing Application

Pin to quick picksGlaxosmithkline Regulatory News (GSK)

Glaxosmithkline Information

Share Price Information for Glaxosmithkline (GSK)

Share Price is delayed by 15 minutes
Get Live Data
1950.00    -7.50 (-0.38%)
Bid:
1954.50
Ask:
1955.00
Spread: 0.50 (0.026%)
Market Cap: £78.13b
GSK Live PriceLast checked at - London Stock Exchange

Intraday Glaxosmithkline Share Chart

Block Listing Application

11 Dec 2025 09:00

RNS Number : 0709L
GSK PLC
11 December 2025
 

 

Issued: 11 December 2025, London UK

 

Block Listing Application

 

 

Application has been made to the Financial Conduct Authority and the London Stock Exchange plc for a total of 250,000 Ordinary Shares of 31¼p each ('Shares') to be admitted to the Official List.

 

The Shares are being reserved under a block listing and will be issued under the GlaxoSmithKline plc Share Save Plan 2022.

 

When issued, the Shares will rank pari passu with the existing Ordinary Shares of 31¼p each.

 

Admission is expected to be effective on 12 December 2025.

 

 

 

 

V A Whyte

Company Secretary

 

11 December 2025

 

 

About GSK

GSK is a global biopharma company with a purpose to unite science, technology, and talent to get ahead of disease together. Find out more at www.gsk.com.

 

Registered in England & Wales:

No. 3888792

 

Registered Office:

79 New Oxford Street

London

WC1A 1DG

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ALSPKKBDABDDFBD
12345678910
Date   Source Headline
21st Nov 20257:00 amRNSTransaction in Own Shares
20th Nov 20257:00 amRNSTransaction in Own Shares
19th Nov 20257:15 amRNSTransfer of Treasury Shares
19th Nov 20257:00 amRNSTransaction in Own Shares
18th Nov 20253:30 pmRNSDirector/PDMR Shareholding
18th Nov 20257:00 amRNSTransaction in Own Shares
17th Nov 20257:00 amRNSTransaction in Own Shares
14th Nov 20257:00 amRNSTransaction in Own Shares
13th Nov 20253:30 pmRNSDirector/PDMR Shareholding
13th Nov 20257:00 amRNSTransaction in Own Shares
12th Nov 20253:30 pmRNSBlock listing Interim Review
12th Nov 20257:00 amRNSTransaction in Own Shares
11th Nov 20257:00 amRNSTransaction in Own Shares
10th Nov 20253:00 pmRNSGSK publishes provisional dividend dates
10th Nov 20257:00 amRNSTransaction in Own Shares
7th Nov 20257:00 amRNSTransaction in Own Shares
6th Nov 20257:00 amRNSTransaction in Own Shares
5th Nov 20257:00 amRNSTransaction in Own Shares
4th Nov 20257:00 amRNSTransaction in Own Shares
3rd Nov 20253:00 pmRNSTotal Voting Rights
3rd Nov 20257:00 amRNSTransaction in Own Shares
31st Oct 20257:00 amRNSTransaction in Own Shares
30th Oct 20253:30 pmRNSDirector/PDMR Shareholding
30th Oct 20257:00 amRNSTransaction in Own Shares
29th Oct 20257:05 amRNSTransaction in Own Shares
29th Oct 20257:00 amRNS3rd Quarter Results
28th Oct 20257:00 amRNSTransaction in Own Shares
28th Oct 20257:00 amRNSGSK ADC gets orphan drug designation in the EU
27th Oct 20257:00 amRNSTransaction in Own Shares
24th Oct 20257:00 amRNSBlenrep approved by US FDA in multiple myeloma
24th Oct 20257:00 amRNSTransaction in Own Shares
23rd Oct 20257:00 amRNSTransaction in Own Shares
22nd Oct 20257:05 amRNSPositive data for low carbon version Ventolin MDI
22nd Oct 20257:00 amRNSTransaction in Own Shares
22nd Oct 20257:00 amRNSLatozinemab data read out
21st Oct 20257:05 amRNSPositive CHMP Opinion for GSK on Shingrix PFS
21st Oct 20257:00 amRNSTransaction in Own Shares
21st Oct 20257:00 amRNSGSK share positive Ph3 data on tebipenem HBr
20th Oct 20257:00 amRNSTransaction in Own Shares
17th Oct 20257:00 amRNSTransaction in Own Shares
16th Oct 20253:30 pmRNSDirector/PDMR Shareholding
16th Oct 20257:00 amRNSTransaction in Own Shares
15th Oct 20253:30 pmRNSDirector/PDMR Shareholding
15th Oct 20257:00 amRNSTransaction in Own Shares
14th Oct 20257:00 amRNSGSK receives expanded Shingrix approval in China
14th Oct 20257:00 amRNSTransaction in Own Shares
13th Oct 20253:30 pmRNSDirector/PDMR Shareholding
13th Oct 20257:00 amRNSTransaction in Own Shares
10th Oct 20253:30 pmRNSDirector/PDMR Shareholding
10th Oct 20257:00 amRNSTransaction in Own Shares
12345678910

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Recently viewed
DRTY
DRTY.L
LSE
0.00%
AO04
Citi Fun 26
LSE
0.00%
SEC
Strategic Eqty
LSE
-3.94%
ULE
ULE.L
LSE
0.00%
MJPU
Ubs Msci Jp Usd
LSE
0.14%
Trending
RRR
Red Rock Resources
LSE
4.35%
CBG
Close Bros
LSE
-0.27%
GGP
Greatland Resources
LSE
-6.61%
MCG
Mobico Group
LSE
3.51%
80M
80 Mile
LSE
-1.54%